Csenge Advisory Group
- SEC CIK
- 0001715593
- Latest filing
- Aug 10, 2026
PRQR holding history
ProQR Therapeutics N.V. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PRQR overviewAll 13F holders of PRQRFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q3 2024 | 10,000 | $18.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,000 | $16.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,000 | $22.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,000 | $19.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,000 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,000 | $16.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,000 | $21.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,000 | $37.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,000 | $7.00K | <0.1% | +10,000 | New | Holders |